19
APGDI, based in U.S.A, is a pharmaceutical company.
One of their notable products is MIRABEGRON, with a corresponding application number 202611 and regulatory information .
proudly manufactured in the
approval since 2012-06-28
APGDI's MYRBETRIQ TABLET, EXTENDED RELEASE;ORAL, medication with 50MG of MIRABEGRON.
18
APGDI, based in U.S.A, is a pharmaceutical company.
One of their notable products is MIRABEGRON, with a corresponding application number 202611 and regulatory information .
proudly manufactured in the
approval since 2012-06-28
APGDI's MYRBETRIQ TABLET, EXTENDED RELEASE;ORAL, medication with 25MG of MIRABEGRON.